Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.
about
Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probesValidation of the Cancer BioChip System as a 3D siRNA screening tool for breast cancer targetsIncreased expression of cathepsin L: a novel independent prognostic marker of worse outcome in hepatocellular carcinoma patients.Cathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2/M cell cycle arrest and DNA damage.Cathepsin L targeting in cancer treatment.Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model.Knockdown of cathepsin L sensitizes ovarian cancer cells to chemotherapyOverexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer.Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.Cathepsin L in metastatic bone disease: therapeutic implications.Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells?Inhibition of cathepsin L lowers the apoptotic threshold of glioblastoma cells by up-regulating p53 and transcription of caspases 3 and 7.Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.The role of C/EBP-β LIP in multidrug resistance.A new nuclear protease with cathepsin L properties is present in HeLa and Caco-2 cells.A micRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition.Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes.Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant Leishmania donovani
P2860
Q26827307-C48ABF21-8689-4B92-9A0F-02E1F6596BE7Q31103913-7AA2B2B0-DD15-47A3-9429-3F4703C0102CQ34482559-78BB78B8-C071-49F1-AF6B-6FECF94B1AB9Q35669806-CF7783ED-EB53-4055-A6C1-2B0EF688F8FDQ36218199-FFCF6774-A068-4C33-B30C-D437C3B07CB6Q36723297-625C828A-F04E-4482-9FCD-15F2C7C4E9C5Q36954656-B238AC68-2DBD-46B6-AF47-7CA80C6A6029Q37564630-EB07A677-D7B8-4FFC-9861-AB10389232C4Q37642507-7EEAECA5-9464-40C0-9F8D-88AD77EA9762Q37724780-78A717D9-6235-4E4F-A230-AAF5E8B9C608Q39296611-48563347-EB0E-4D7B-9849-217404D197C7Q39560226-B39C8D0B-9EA2-4B31-9868-72E52082DEA1Q42273053-27B0AF67-16A6-421B-BAD9-D22C260EF022Q42474136-E1500B29-FAD3-4259-9693-94D26AA491BEQ43053135-F9EA065F-8091-4D46-BFBA-9C23316FBDA1Q50006155-78EE1364-96B3-4170-86AC-1D5C6FB9E08FQ55023666-E24132AF-BC87-49B1-86A0-B50DB039873AQ59003551-6DEE30A6-86F7-497C-A81F-F7828F72C2E4
P2860
Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cathepsin L inhibition suppres ...... in vivo: a putative mechanism.
@ast
Cathepsin L inhibition suppres ...... in vivo: a putative mechanism.
@en
type
label
Cathepsin L inhibition suppres ...... in vivo: a putative mechanism.
@ast
Cathepsin L inhibition suppres ...... in vivo: a putative mechanism.
@en
prefLabel
Cathepsin L inhibition suppres ...... in vivo: a putative mechanism.
@ast
Cathepsin L inhibition suppres ...... in vivo: a putative mechanism.
@en
P2093
P2860
P1476
Cathepsin L inhibition suppres ...... in vivo: a putative mechanism
@en
P2093
Abdelhadi Rebbaa
Bernard L Mirkin
Christine Gallati
Pauline M Chou
Usawadee Dier
P2860
P304
P356
10.1152/AJPCELL.00082.2008
P577
2008-10-29T00:00:00Z